MedicarePartD.guide

A non-government resource built from CMS public data

SGLT2 inhibitors on every 2026 Kansas Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Kansas cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

SGLT2 inhibitors by 2026 Kansas Part D plan
DrugBlue MedicareRx Essentials$0.00/moS5726-020Blue MedicareRx Value$0.70/moS5726-013HealthSpring Assurance Rx$6.70/moS5617-118Wellcare Value Script$9.60/moS4802-157Wellcare Classic$14.70/moS4802-088Humana Basic Rx Plan$15.50/moS5884-109Humana Value Rx Plan$55.60/moS5884-203Blue MedicareRx Plus$67.40/moS5726-014SilverScript Choice$88.30/moS5601-048AARP Medicare Rx Saver from UHC$105.40/moS5921-369Humana Premier Rx Plan$116.30/moS5884-170AARP Medicare Rx Preferred from UHC$147.00/moS5921-405
JardianceempagliflozinTier 320%QL 30/30dTier 318%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dTier 315%QL 30/30d
FarxigadapagliflozinNot coveredNot coveredTier 325%QL 30/30dNot coveredNot coveredTier 325%QL 30/30dTier 320%QL 30/30dNot coveredTier 318%QL 30/30dNot coveredTier 3$45.00QL 30/30dNot covered
dapagliflozingeneric FarxigaTier 320%QL 30/30dTier 318%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dTier 315%QL 30/30d
InvokanacanagliflozinNot coveredNot coveredNot coveredTier 440%QL 60/30dTier 426%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SteglatroertugliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
InpefasotagliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.